Listen to this discussion on SBS Sinhala Radio to find out how the Novavax vaccine differs from ... Ease into the English language and Australian culture. We make learning English convenient ...

Novavax reported Q4 sales of $88.31 million, beating estimates despite a decline. The company shifts focus to partnerships ...

Novavax stock (NVAX) skyrocketed Friday, up 120% on the news that French drug and vaccine giant Sanofi (SNY) is investing $1.2 billion in a deal for Novavax's COVID-19 vaccine as well as a ...

Novavax NVAX is expected to report fourth-quarter and full-year 2024 earnings later this month. In the last reported quarter, the company’s earnings beat estimates by 12.64%. The Zacks Consensus ...

Shares of Novavax declined after the company reaffirmed full-year revenue and fellow vaccine maker Moderna lowered its guidance. Novavax stock was down 7.3%, to $8.64, on Monday but is up about 89 ...

Bullish option flow detected in Novavax (NVAX) with 23,789 calls trading, 3x expected, and implied vol increasing over 8 points to 114.25%. Feb-25 8.5 calls and Mar-25 7.5 puts are the most active ...

Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and twelve months ended December 31, 2024. Novavax, Inc. (Nasdaq: NVAX), a ...